}11&X3)%?*N(|L$AA36T.@J=W{FKS&{0(M%AT[(
SYSTEM PROCESSING...
}11&X3)%?*N(|L$AA36T.@J=W{FKS&{0(M%AT[(
SYSTEM PROCESSING...
Posted: 2025-04-12 05:06:13 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-12 05:06:42 UTC
Verified By
Rollup News
A new study reveals that cancer activates a cytokine-sensing brain circuit, leading to decreased motivation in late-stage cancer patients. The research identifies a specific circuit involving IL-6 and dopamine suppression in the nucleus accumbens, offering potential therapeutic targets for treating apathy in advanced disease.
Cancer-induced apathy is linked to a specific brain circuit activated by inflammation.
IL-6 plays a key role in suppressing dopamine release, leading to loss of motivation.
Targeting this circuit can rescue apathy without stopping cancer, offering new therapeutic avenues.
Understanding the neurological basis of apathy in cancer patients.
Developing effective treatments for cancer cachexia-related apathy.
Bridging the gap between physical disease and psychiatric symptoms.